Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
Adv Nutr ; 10(6): 1181-1200, 2019 11 01.
Artículo en Inglés | MEDLINE | ID: mdl-31728505

RESUMEN

Nutrition plays an important role in health promotion and disease prevention and treatment across the lifespan. Physicians and other healthcare professionals are expected to counsel patients about nutrition, but recent surveys report minimal to no improvements in medical nutrition education in US medical schools. A workshop sponsored by the National Heart, Lung, and Blood Institute addressed this gap in knowledge by convening experts in clinical and academic health professional schools. Representatives from the National Board of Medical Examiners, the Accreditation Council for Graduate Medical Education, the Liaison Committee on Medical Education, and the American Society for Nutrition provided relevant presentations. Reported is an overview of lessons learned from nutrition education efforts in medical schools and health professional schools including interprofessional domains and competency-based nutrition education. Proposed is a framework for coordinating activities of various entities using a public-private partnership platform. Recommendations for nutrition research and accreditation are provided.


Asunto(s)
Competencia Clínica , Educación Médica , Personal de Salud/educación , Comunicación Interdisciplinaria , Terapia Nutricional , Ciencias de la Nutrición/educación , Acreditación , Curriculum , Conocimientos, Actitudes y Práctica en Salud , Humanos , Internado y Residencia/métodos , Concesión de Licencias , National Heart, Lung, and Blood Institute (U.S.) , Médicos , Estudiantes de Medicina , Encuestas y Cuestionarios , Estados Unidos
2.
J Nutr ; 145(7): 1630-4, 2015 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-26019244

RESUMEN

BACKGROUND: One-half of US adults report using a dietary supplement. NHANES has traditionally assessed dietary supplement use via a 30-d questionnaire but in 2007 added a supplement module to the 24-h dietary recall (24HR). OBJECTIVE: We compared these 2 dietary assessment methods, examined potential biases in the methods, and determined the effect that instrument choice had on estimates of prevalence of multivitamin/multimineral dietary supplement (MVMM) use. METHODS: We described prevalence of dietary supplement use by age, sex, and assessment instrument in 12,285 adults in the United States (>19 y of age) from NHANES 2007-2010. RESULTS: When using data from the questionnaire alone, 29.3% ± 1.0% of men and 35.5% ± 1.0% of women were users of MVMMs, whereas data from the 24HR only produced prevalence estimates of 26.3% ± 1.1% for men and 33.2% ± 1.0% for women. When using data from both instruments combined, 32.3% ± 1.2% of men and 39.5% ± 1.1% of women were classified as MVMM users. Prevalence estimates were significantly higher by 2-9% in all age-sex groups when using information from both instruments combined than when using data from either instrument individually. A digit preference bias and flattened slope phenomenon were observed in responses to the dietary supplement questionnaire. A majority (67%) of MVMMs were captured on both instruments, whereas 19% additional MVMMs were captured on the questionnaire and 14% additional on the 24HR. Of those captured only on the 24HR, 26% had missing label information, whereas only 12% and 9% of those captured on the questionnaire or both, respectively, had missing information. CONCLUSIONS: Use of both the dietary supplement questionnaire and the 24HR can provide advantages to researchers over the use of a single instrument and potentially capture a larger fraction of dietary supplement users.


Asunto(s)
Suplementos Dietéticos/estadística & datos numéricos , Micronutrientes/administración & dosificación , Adulto , Anciano , Estudios Transversales , Femenino , Humanos , Masculino , Recuerdo Mental , Persona de Mediana Edad , Evaluación Nutricional , Encuestas Nutricionales , Encuestas y Cuestionarios , Estados Unidos , Adulto Joven
3.
Cancer Prev Res (Phila) ; 8(3): 181-9, 2015 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-25586902

RESUMEN

The Allium genus includes garlic, onions, shallots, leeks, and chives. These vegetables are popular in cuisines worldwide and are valued for their potential medicinal properties. Epidemiologic studies, while limited in their abilities to assess Allium consumption, indicate some associations of Allium vegetable consumption with decreased risk of cancer, particularly cancers of the gastrointestinal tract. Limited intervention studies have been conducted to support these associations. The majority of supportive evidence on Allium vegetables cancer-preventive effects comes from mechanistic studies. These studies highlight potential mechanisms of individual sulfur-containing compounds and of various preparations and extracts of these vegetables, including decreased bioactivation of carcinogens, antimicrobial activities, and redox modification. Allium vegetables and their components have effects at each stage of carcinogenesis and affect many biologic processes that modify cancer risk. This review discusses the cancer-preventive effects of Allium vegetables, particularly garlic and onions, and their bioactive sulfur compounds and highlights research gaps.


Asunto(s)
Ajo/química , Neoplasias/prevención & control , Cebollas/química , Extractos Vegetales/uso terapéutico , Animales , Humanos
4.
Cancer Prev Res (Phila) ; 7(2): 246-54, 2014 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-24346344

RESUMEN

Urinary bladder cancer prevention studies were performed with the nonsteroidal anti-inflammatory drugs (NSAID) naproxen (a standard NSAID with a good cardiovascular profile), sulindac, and their nitric oxide (NO) derivatives. In addition, the effects of the ornithine decarboxylase inhibitor, difluoromethylornithine (DFMO), alone or combined with a suboptimal dose of naproxen or sulindac was examined. Agents were evaluated at their human equivalent doses (HED), as well as at lower doses. In the hydroxybutyl(butyl)nitrosamine (OH-BBN) model of urinary bladder cancer, naproxen (400 or 75 ppm) and sulindac (400 ppm) reduced the incidence of large bladder cancers by 82%, 68%, and 44%, respectively, when the agents were initially given 3 months after the final dose of the carcinogen; microscopic cancers already existed. NO-naproxen was highly effective, whereas NO-sulindac was inactive. To further compare naproxen and NO-naproxen, we examined their effects on gene expression in rat livers following a 7-day exposure. Limited, but similar, gene expression changes in the liver were induced by both agents, implying that the primary effects of both are mediated by the parent NSAID. When agents were initiated 2 weeks after the last administration of OH-BBN, DFMO at 1,000 ppm had limited activity, a low dose of naproxen (75 ppm) and sulindac (150 ppm) were highly and marginally effective. Combining DFMO with suboptimal doses of naproxen had minimal effects, whereas the combination of DMFO and sulindac was more active than either agent alone. Thus, naproxen and NO-naproxen were highly effective, whereas sulindac was moderately effective in the OH-BBN model at their HEDs.


Asunto(s)
Antiinflamatorios no Esteroideos/administración & dosificación , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Eflornitina/administración & dosificación , Neoplasias Experimentales/prevención & control , Óxido Nítrico/administración & dosificación , Neoplasias de la Vejiga Urinaria/prevención & control , Animales , Quimioprevención/métodos , Evaluación Preclínica de Medicamentos , Femenino , Naproxeno/administración & dosificación , Naproxeno/análogos & derivados , Neoplasias Experimentales/inducido químicamente , Ratas , Ratas Endogámicas F344 , Sulindac/administración & dosificación , Neoplasias de la Vejiga Urinaria/inducido químicamente
5.
Nutrients ; 5(4): 1122-48, 2013 Apr 03.
Artículo en Inglés | MEDLINE | ID: mdl-23552052

RESUMEN

The Selenium and Vitamin E Cancer Prevention Trial (SELECT) was conducted to assess the efficacy of selenium and vitamin E alone, and in combination, on the incidence of prostate cancer. This randomized, double-blind, placebo-controlled, 2 × 2 factorial design clinical trial found that neither selenium nor vitamin E reduced the incidence of prostate cancer after seven years and that vitamin E was associated with a 17% increased risk of prostate cancer compared to placebo. The null result was surprising given the strong preclinical and clinical evidence suggesting chemopreventive activity of selenium. Potential explanations for the null findings include the agent formulation and dose, the characteristics of the cohort, and the study design. It is likely that only specific subpopulations may benefit from selenium supplementation; therefore, future studies should consider the baseline selenium status of the participants, age of the cohort, and genotype of specific selenoproteins, among other characteristics, in order to determine the activity of selenium in cancer prevention.


Asunto(s)
Anticarcinógenos/administración & dosificación , Suplementos Dietéticos , Neoplasias de la Próstata/prevención & control , Selenio/administración & dosificación , Vitamina E/administración & dosificación , Anciano , Animales , Anticarcinógenos/efectos adversos , Anticarcinógenos/metabolismo , Suplementos Dietéticos/efectos adversos , Combinación de Medicamentos , Humanos , Incidencia , Masculino , Persona de Mediana Edad , Neoplasias de la Próstata/epidemiología , Ensayos Clínicos Controlados Aleatorios como Asunto , Factores de Riesgo , Selenio/metabolismo , Factores de Tiempo , Resultado del Tratamiento , Vitamina E/efectos adversos , Vitamina E/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA